Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

16.99
Delayed Data
As of 4:00pm ET
 -0.80 / -4.50%
Today’s Change
4.03
Today|||52-Week Range
22.00
+55.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$736.3M

Company Description

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Contact Information

PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield New Jersey 07080-2449
P:(908) 222-7000
Investor Relations:

Employees

Shareholders

Other institutional53.63%
Mutual fund holders28.48%
Individual stakeholders20.08%

Top Executives

Stuart W. PeltzChief Executive Officer & Director
Marcio SouzaChief Operating Officer
Christine UtterTreasurer, Chief Financial & Accounting Officer
Neil Gregory AlmsteadExecutive VP-Research, Operations & Technology
Tuyen OngChief Medical Officer